Abstract
There is a perceived global need to bridge the existing gap between researchers and other stakeholders to make research more helpful and to realign “the mismatch between what clinical researchers do and what patients need”. The EMCDDA carried out a pilot analysis to explore the gaps in research on treatment for drug dependence as indicated by systematic reviewers of studies on effectiveness of interventions together with a stakeholder’s consultation to ensure a broader participation in the definition of research needs. The rough comparisons of the gaps identified by the researchers in the reviews and those suggested by the stakeholders reflect their different perception of research. The reviewers focus on the quality of studies and on how this may impair reaching conclusive evidence, while the stakeholders are more concerned by the management of effective interventions and by the needs of specific patients. With this exercise, the EMCDDA wants to contribute to the broader debate on how to translate evidence into action and it offers a possible way to support decision makers to set the health research agenda.
Declaration of interest
The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.
Notes
1The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the European Union Agency for drugs and drug addiction which was created to provide the EU and its Member States with a factual overview of European drug problems and to offer policymakers the data they need for drawing up informed drug laws and strategies. It also helps professionals and practitioners working in the field pinpoint best practice and new areas of research.